Kern Singh to Spondylolisthesis
This is a "connection" page, showing publications Kern Singh has written about Spondylolisthesis.
Connection Strength
11.395
-
Single-level Minimally Invasive Transforaminal Lumbar Interbody Fusion Versus Anterior Lumbar Interbody Fusion for the Surgical Treatment of Isthmic Spondylolisthesis. J Am Acad Orthop Surg. 2022 Nov 01; 30(21):e1382-e1390.
Score: 0.815
-
Minimally Invasive Transforaminal versus Anterior Lumbar Interbody Fusion in Patients Undergoing Revision Fusion: Clinical Outcome Comparison. World Neurosurg. 2022 Nov; 167:e1208-e1218.
Score: 0.814
-
Comparing Patient-Reported Outcomes in Patients Undergoing Lumbar Fusion for Isthmic Spondylolisthesis with Predominant Back Pain versus Predominant Leg Pain Symptoms. World Neurosurg. 2022 Oct; 166:e672-e680.
Score: 0.809
-
Risk Assessment of Anterior Lumbar Interbody Fusion Access in Degenerative Spinal Conditions. Clin Spine Surg. 2022 08 01; 35(7):E601-E609.
Score: 0.790
-
Commentary: Robotic-Assisted vs Nonrobotic-Assisted Minimally Invasive Transforaminal Lumbar Interbody Fusion: A Cost-Utility Analysis. Neurosurgery. 2022 02 01; 90(2):e32-e33.
Score: 0.781
-
Preoperative Duration of Symptoms Does Not Affect Outcomes of Anterior Lumbar Interbody Fusion. Neurosurgery. 2022 02 01; 90(2):215-220.
Score: 0.781
-
Influence of Preoperative 12-Item Short Form Mental Composite Score on Clinical Outcomes in an Isthmic Spondylolisthesis Population Undergoing Minimally Invasive Transforaminal Lumbar Interbody Fusion. World Neurosurg. 2022 02; 158:e1022-e1030.
Score: 0.774
-
Diabetes Does Not Increase Complications, Length of Stay, or Hospital Costs After Minimally Invasive Transforaminal Lumbar Interbody Fusion. Clin Spine Surg. 2020 08; 33(7):E307-E311.
Score: 0.704
-
The Effect of Preoperative Symptom Duration on Postoperative Outcomes After Minimally Invasive Transforaminal Lumbar Interbody Fusion. Clin Spine Surg. 2020 07; 33(6):E263-E268.
Score: 0.700
-
Complications Following Minimally Invasive Transforaminal Lumbar Interbody Fusion: Incidence, Independent Risk Factors, and Clinical Impact. Clin Spine Surg. 2020 06; 33(5):E236-E240.
Score: 0.696
-
Impact of local steroid application in a minimally invasive transforaminal lumbar interbody fusion: results of a prospective, randomized, single-blind trial. J Neurosurg Spine. 2018 11 09; 30(2):222-227.
Score: 0.625
-
Risk Factors Associated With Failure to Reach Minimal Clinically Important Difference in Patient-reported Outcomes Following Minimally Invasive Transforaminal Lumbar Interbody Fusion for Spondylolisthesis. Clin Spine Surg. 2018 02; 31(1):E92-E97.
Score: 0.592
-
The Utility of Routinely Obtaining Postoperative Laboratory Studies Following a Minimally Invasive Transforaminal Lumbar Interbody Fusion. Clin Spine Surg. 2017 Dec; 30(10):E1405-E1410.
Score: 0.585
-
Lumbar Spine Injuries in the Athlete. Instr Course Lect. 2017 Feb 15; 66:403-408.
Score: 0.554
-
A perioperative cost analysis comparing single-level minimally invasive and open transforaminal lumbar interbody fusion. Spine J. 2014 Aug 01; 14(8):1694-701.
Score: 0.442
-
Minimally invasive transforaminal lumbar interbody fusion: one surgeon's learning curve. Spine J. 2014 Aug 01; 14(8):1460-5.
Score: 0.439
-
Use of recombinant human bone morphogenetic protein-2 as an adjunct in posterolateral lumbar spine fusion: a prospective CT-scan analysis at one and two years. J Spinal Disord Tech. 2006 Aug; 19(6):416-23.
Score: 0.267
-
Minimally Invasive Transforaminal Lumbar Interbody Fusion. J Spinal Disord Tech. 2015 Jul; 28(6):222-5.
Score: 0.124
-
A comparison of perioperative costs and outcomes in patients with and without workers' compensation claims treated with minimally invasive or open transforaminal lumbar interbody fusion. Spine (Phila Pa 1976). 2012 Oct 15; 37(22):1914-9.
Score: 0.103